Compare Unichem Lab with AANJANEYA LIFECARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs DR. DATSONS LABS - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB DR. DATSONS LABS UNICHEM LAB/
DR. DATSONS LABS
 
P/E (TTM) x 62.8 -10.9 - View Chart
P/BV x 0.7 0.2 415.5% View Chart
Dividend Yield % 2.1 0.0 -  

Financials

 UNICHEM LAB   DR. DATSONS LABS
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
DR. DATSONS LABS
Mar-14
UNICHEM LAB/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs292126 232.5%   
Low Rs18231 589.0%   
Sales per share (Unadj.) Rs167.7133.0 126.1%  
Earnings per share (Unadj.) Rs-3.60.2 -2,394.8%  
Cash flow per share (Unadj.) Rs5.96.6 89.9%  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %1.70-  
Book value per share (Unadj.) Rs372.3128.8 289.0%  
Shares outstanding (eoy) m70.3831.66 222.3%   
Bonus/Rights/Conversions ESOPFCCB-  
Price / Sales ratio x1.40.6 240.2%   
Avg P/E ratio x-65.3516.1 -12.6%  
P/CF ratio (eoy) x39.911.8 336.8%  
Price / Book Value ratio x0.60.6 104.8%  
Dividend payout %-110.20-   
Avg Mkt Cap Rs m16,6802,477 673.3%   
No. of employees `0002.6NA-   
Total wages/salary Rs m2,39356 4,273.6%   
Avg. sales/employee Rs Th4,535.2NM-  
Avg. wages/employee Rs Th919.8NM-  
Avg. net profit/employee Rs Th-98.2NM-  
INCOME DATA
Net Sales Rs m11,8014,211 280.3%  
Other income Rs m98479 1,250.4%   
Total revenues Rs m12,7854,289 298.1%   
Gross profit Rs m-835569 -146.8%  
Depreciation Rs m674204 329.6%   
Interest Rs m75430 17.5%   
Profit before tax Rs m-60013 -4,722.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m1-2 -38.9%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-3436 -5,630.7%   
Profit after tax Rs m-2565 -5,323.5%  
Gross profit margin %-7.113.5 -52.4%  
Effective tax rate %57.348.0 119.2%   
Net profit margin %-2.20.1 -1,899.5%  
BALANCE SHEET DATA
Current assets Rs m20,3846,852 297.5%   
Current liabilities Rs m5,0296,711 74.9%   
Net working cap to sales %130.13.3 3,885.6%  
Current ratio x4.11.0 397.0%  
Inventory Days Days105161 65.1%  
Debtors Days Days135318 42.4%  
Net fixed assets Rs m9,0233,673 245.7%   
Share capital Rs m141317 44.5%   
"Free" reserves Rs m26,0583,761 692.9%   
Net worth Rs m26,1994,078 642.5%   
Long term debt Rs m01,671 0.0%   
Total assets Rs m31,49612,633 249.3%  
Interest coverage x-7.01.0 -677.5%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.40.3 112.4%   
Return on assets %-0.63.4 -16.6%  
Return on equity %-1.00.1 -828.5%  
Return on capital %-2.07.7 -26.1%  
Exports to sales %69.422.9 303.1%   
Imports to sales %014.3 0.0%   
Exports (fob) Rs m8,188964 849.4%   
Imports (cif) Rs mNA602 0.0%   
Fx inflow Rs m8,188964 849.4%   
Fx outflow Rs m596607 98.2%   
Net fx Rs m7,592357 2,127.2%   
CASH FLOW
From Operations Rs m-3,2781,345 -243.7%  
From Investments Rs m-2,860-2,256 126.8%  
From Financial Activity Rs m-24-1,200 2.0%  
Net Cashflow Rs m-4,690-2,111 222.2%  

Share Holding

Indian Promoters % 50.1 4.5 1,106.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 0.0 -  
FIIs % 3.0 1.4 222.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 94.1 33.7%  
Shareholders   20,176 20,807 97.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   AJANTA PHARMA  GLENMARK PHARMA  SUN PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

UNICHEM LAB Announces Quarterly Results (4QFY19); Net Profit Up 31.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, UNICHEM LAB has posted a net profit of Rs 37 m (up 31.7% YoY). Sales on the other hand came in at Rs 3 bn (up 35.1% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (3QFY19); Net Profit Up 110.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, UNICHEM LAB has posted a net profit of Rs 63 m (up 110.9% YoY). Sales on the other hand came in at Rs 2 bn (up 53.8% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Sep 20, 2019 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB - ASTRAZENECA PHARMA COMPARISON

COMPARE UNICHEM LAB WITH

MARKET STATS